Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of North Carolina, Chapel Hill
Age
14–24
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Adolescents ages 14-24 attending prenatal care
Greater than 20 weeks estimated gestational age
English or Spanish-speaking
Desire to use the contraceptive implant for contraception postpartum
Anticipated delivery of a healthy infant vaginally or by cesarean.
You may not be if
Participants will not be eligible for participation if they have any contraindications to contraceptive implant use, including
current or past history of thrombosis or thromboembolic disorders
hepatic tumors (benign or malignant)
active liver disease
undiagnosed abnormal genital bleeding
known or suspected carcinoma of the breast (or a personal history of breast cancer)
hypersensitivity to any of the components of the contraceptive implant.
Current use of any medications known to induce hepatic enzymes, including but not limited to: barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, St. John's wort, or topiramate
Characteristics that would preclude involvement after delivery:
Adolescent women who are not competent to consent, secondary to stress from the labor process, for example severe pain or sleep deprivation, will not be offered enrolment into the trial
